Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 33, Pages E7776-E7785
Publisher
Proceedings of the National Academy of Sciences
Online
2018-07-31
DOI
10.1073/pnas.1805523115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asparagine bioavailability governs metastasis in a model of breast cancer
- (2018) Simon R. V. Knott et al. NATURE
- General control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice
- (2016) Lindsey Phillipson-Weiner et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL
- (2016) Usman Ali et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
- (2016) Abigail S. Krall et al. Nature Communications
- GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2
- (2015) Jiangbin Ye et al. GENES & DEVELOPMENT
- Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma
- (2015) Jean-Baptiste Bachet et al. PANCREAS
- Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
- (2015) Shih-Hsiang Chen Pediatrics and Neonatology
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
- (2014) Wing H. Tong et al. BLOOD
- Asparaginase in the treatment of non-ALL hematologic malignancies
- (2014) Ashkan Emadi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia
- (2014) Michael J Burke Future Oncology
- Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
- (2014) Ji Zhang et al. MOLECULAR CELL
- Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2
- (2014) Jean-Francois Brazeau et al. ACS Medicinal Chemistry Letters
- The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment
- (2013) Gabriel J. Wilson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
- (2013) C. Atkins et al. CANCER RESEARCH
- A sulfoximine-based inhibitor of human asparagine synthetase kills l-asparaginase-resistant leukemia cells
- (2012) Hideyuki Ikeuchi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation
- (2012) Emmanuelle Dufour et al. PANCREAS
- The Transcription Factor Network Associated With the Amino Acid Response in Mammalian Cells
- (2012) Michael S. Kilberg et al. Advances in Nutrition
- ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia
- (2011) J. Rousseau et al. BLOOD
- The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
- (2010) Jiangbin Ye et al. EMBO JOURNAL
- A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity
- (2010) S-H Chen et al. LEUKEMIA
- Identification of a Novel Amino Acid Response Pathway Triggering ATF2 Phosphorylation in Mammals
- (2009) C. Chaveroux et al. MOLECULAR AND CELLULAR BIOLOGY
- Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
- (2008) R. Pieters et al. BLOOD
- MEK Signaling Is Required for Phosphorylation of eIF2α following Amino Acid Limitation of HepG2 Human Hepatoma Cells
- (2008) Michelle M. Thiaville et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started